Late‐onset acute graft‐versus‐host disease (GVHD) predominantly occurs after reduced‐
intensity conditioning (RIC) regimen‐based allogeneic transplantation or in the context of …

Graft-versus-Host Disease (GVHD) has remained the most frequent complication after
allogeneic hematopoietic cell transplantation (HCT). GVHD was first described as …

Acute graft‐versus‐host disease (GvHD) is a frequent complication of allogeneic
haemopoietic stem cell transplantation (HSCT) and donor lymphocyte infusions (DLI). Its …

Acute graft-versus-host disease (GVHD), initiated by the reaction of donor T lymphocytes
against nonshared recipient antigens, typically leads to a clinical syndrome characterized by …

Management of steroid-resistant or steroid-refractory acute graft-versus-host disease
(aGVHD) poses one of the most vexing and difficult problems faced by transplantation …

Acute graft-versus-host disease (GVHD) remains a leading cause of morbidity and
nonrelapse mortality after allogeneic hematopoietic cell transplantation. The clinical staging …

Despite prophylaxis with immunosuppressive agents or a variety of other approaches, many
patients suffer from acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic …

PURPOSE Accurate and reproducible methods to diagnose, grade, and report acute graft-
versus-host disease (GVHD) are critical for the evaluation of therapies and biomarkers …

Acute graft-versus-host disease (GVHD) is a significant cause of morbidity and mortality
following allogeneic hematopoietic cell transplantation (HCT). This analysis of 168 patients …

Acute graft-versus-host disease (aGVHD) continues to be a problem in allogeneic
transplantation. Recent advances in the understanding of the induction and propagation of …